查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599295

病毒惰性市场：按产品、方法、应用和最终用户划分 - 全球预测 2025-2030

Viral Inactivation Market by Product (Kits & Reagents, Services, Viral Inactivation Systems & Accessories), Method (Pasteurization, Solvent Detergent Method), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年病毒惰性市场价值为9.7741亿美元，预计到2024年将达到11.1948亿美元，复合年增长率为14.62%，预计到2030年将达到25.4174亿美元。

病毒惰性是生物製药和医疗保健中的重要过程，旨在中和生技药品、疫苗和血液製品中潜在的病毒污染物。这个过程对于确保药品安全性和有效性以及保护公众健康至关重要。此外，其应用涵盖製药、生物技术、输血和诊断实验室等各个领域，最终用途为医院、诊断中心、研究机构等。市场的主要驱动力是生物安全监管标准的不断提高以及对有效和安全治疗药物的需求不断增加。此外，溶剂/清洁剂处理、巴氏杀菌、低 pH 值处理和紫外线照射等技术的进步，能够可靠地惰性病毒，也支持了成长。此外，慢性病盛行率的增加和对个人化医疗的日益关注也扩大了病毒惰性应用的潜力。然而，高营运成本、技术复杂性和严格的监管合规性等挑战可能会阻碍市场成长。特别是在新兴经济体，由于不同的法规和基础设施差异，市场面临地理限制。机会在于采用创新技术和开发多模态灭活平台，可扩大应用范围并提高製程效率。探索更有效、更具成本效益的方法和技术，以适应更新、更具抗药性的病毒株，对于促进成长至关重要。企业应优先投资策略伙伴关係和研发，以有效利用这些机会。儘管市场前景广阔，但复杂的监管环境以及与流程相关的变更对产品品质产生负面影响的可能性仍然是主要障碍。总体而言，透过创新保持领先地位并适应不断变化的监管标准，同时确保成本效益，是希望在病毒惰性市场取得成功的公司的关键策略。

主要市场统计
基准年[2023] 97741万美元
预测年份 [2024] 111,948万美元
预测年份 [2030] 25.4174亿美元
复合年增长率（%） 14.62%

市场动态：快速发展的病毒惰性市场的关键市场洞察

供需的动态交互作用正在改变病毒惰性市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 世界慢性病的增加
    • 政府加大对製药和生技产业的支持
    • 新药认证数量增加
  • 市场限制因素
    • 与製造生物相似药相关的高成本
  • 市场机会
    • 病毒惰性程序中的技术集成
    • 生命科学产业大力研发投入
  • 市场挑战
    • 严格的政府监管指引

波特五力：驾驭病毒惰性市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对病毒惰性市场的影响

外部宏观环境因素在塑造病毒惰性市场的表现动态中起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解病毒惰性市场的竞争状况

对病毒惰性市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵病毒惰性市场厂商绩效评估

FPNV定位矩阵是评估病毒惰性市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製病毒惰性市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对病毒惰性市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球慢性病流行
      • 政府加大对製药和生物技术产业的支持
      • 新药认证数量增加
    • 抑制因素
      • 与製造生物相似药相关的高成本
    • 机会
      • 病毒惰性程序中的技术集成
      • 生命科学产业强劲的研发投入
    • 任务
      • 严格的政府监管指引
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章病毒惰性市场：副产品

  • 试剂套件和试剂
  • 服务
  • 病毒惰性系统及配件

第七章病毒惰性市场：依方法分类

  • 消毒
  • 清洁剂洗涤法

第八章病毒惰性市场：依应用

  • 血液和血液製品
  • 细胞/基因疗法产品
  • 干细胞产品
  • 纸巾和纸巾产品
  • 疫苗和治疗

第九章病毒惰性市场：依最终用户分类

  • 学术研究所
  • 合约调查机构
  • 製药和生物技术公司

第十章美洲病毒惰性市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区病毒惰性市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲病毒惰性市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Cytiva by Danaher Corporation
  • Eurofins Scientific（Ireland）Limited
  • HiMedia Laboratories, LLC
  • Lonza Group Ltd.
  • Merck KGaA
  • Parker Hannifin Corporation
  • PromoCell GmbH
  • Rad Source Technologies, Inc.
  • Sartorius AG
  • Thermo Fisher Scientific Inc
  • WuXi AppTec Co., Ltd.
Product Code: MRR-034B5003039F

The Viral Inactivation Market was valued at USD 977.41 million in 2023, expected to reach USD 1,119.48 million in 2024, and is projected to grow at a CAGR of 14.62%, to USD 2,541.74 million by 2030.

Viral inactivation is a critical process in biopharmaceutical manufacturing and healthcare, designed to neutralize potential viral contaminants in biologics, vaccines, and blood products. This process is essential for ensuring the safety and efficacy of pharmaceutical products, thereby protecting public health. Moreover, its application spans various fields, including pharmaceuticals, biotechnology, blood transfusion, and diagnostic laboratories, with end-use sectors comprising hospitals, diagnostic centers, and research institutions. The market is primarily driven by increasing regulatory standards for biologic safety and the rising demand for effective and safe therapeutics. Growth is further propelled by advancements in technologies such as solvent/detergent treatment, pasteurization, low pH treatment, and UV irradiation, enabling reliable viral inactivation. Additionally, the escalating prevalence of chronic diseases and increased focus on personalized medicine have expanded the potential for viral inactivation applications. However, challenges such as high operational costs, technical complexities, and stringent regulatory compliance may hamper market growth. The market faces geographical limitations due to varying regulations and infrastructure disparities, particularly in developing economies. Opportunities lie in adopting innovative technologies and developing multimodal inactivation platforms, which can broaden applicability and enhance process efficiency. Research into more efficient, cost-effective methods, and technologies that can handle newer and more resistant viral strains are imperative for driving growth. Companies should prioritize strategic partnerships and investment in R&D to harness these opportunities effectively. Despite the promising nature of the market, the intricate regulatory landscape and the possible adverse effects on product quality due to process-induced alterations remain significant hurdles. Overall, staying ahead through innovation and adapting to evolving regulatory standards while ensuring cost-effectiveness are key strategies for businesses aiming to thrive in the viral inactivation market.

KEY MARKET STATISTICS
Base Year [2023] USD 977.41 million
Estimated Year [2024] USD 1,119.48 million
Forecast Year [2030] USD 2,541.74 million
CAGR (%) 14.62%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Viral Inactivation Market

The Viral Inactivation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the global prevalence of chronic diseases
    • Growing government support for pharmaceutical & biotechnology industries
    • Rising number of new drug approvals
  • Market Restraints
    • High costs associated with the manufacture of biosimilar products
  • Market Opportunities
    • Technological integrations in viral inactivation procedures
    • Strong R&D investments in the life sciences industry
  • Market Challenges
    • Strict government regulatory guidelines

Porter's Five Forces: A Strategic Tool for Navigating the Viral Inactivation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Viral Inactivation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Viral Inactivation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Viral Inactivation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Viral Inactivation Market

A detailed market share analysis in the Viral Inactivation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Viral Inactivation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Viral Inactivation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Viral Inactivation Market

A strategic analysis of the Viral Inactivation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Viral Inactivation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Cytiva by Danaher Corporation, Eurofins Scientific (Ireland) Limited, HiMedia Laboratories, LLC, Lonza Group Ltd., Merck KGaA, Parker Hannifin Corporation, PromoCell GmbH, Rad Source Technologies, Inc., Sartorius AG, Thermo Fisher Scientific Inc, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Viral Inactivation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Kits & Reagents, Services, and Viral Inactivation Systems & Accessories.
  • Based on Method, market is studied across Pasteurization and Solvent Detergent Method.
  • Based on Application, market is studied across Blood & Blood Product, Cellular & Gene Therapy Product, Stem Cell Product, Tissues & Tissue Product, and Vaccines & Therapeutic.
  • Based on End User, market is studied across Academic Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the global prevalence of chronic diseases
      • 5.1.1.2. Growing government support for pharmaceutical & biotechnology industries
      • 5.1.1.3. Rising number of new drug approvals
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with the manufacture of biosimilar products
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological integrations in viral inactivation procedures
      • 5.1.3.2. Strong R&D investments in the life sciences industry
    • 5.1.4. Challenges
      • 5.1.4.1. Strict government regulatory guidelines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Viral Inactivation Market, by Product

  • 6.1. Introduction
  • 6.2. Kits & Reagents
  • 6.3. Services
  • 6.4. Viral Inactivation Systems & Accessories

7. Viral Inactivation Market, by Method

  • 7.1. Introduction
  • 7.2. Pasteurization
  • 7.3. Solvent Detergent Method

8. Viral Inactivation Market, by Application

  • 8.1. Introduction
  • 8.2. Blood & Blood Product
  • 8.3. Cellular & Gene Therapy Product
  • 8.4. Stem Cell Product
  • 8.5. Tissues & Tissue Product
  • 8.6. Vaccines & Therapeutic

9. Viral Inactivation Market, by End User

  • 9.1. Introduction
  • 9.2. Academic Research Institutes
  • 9.3. Contract Research Organizations
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Viral Inactivation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Viral Inactivation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Viral Inactivation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Becton, Dickinson and Company
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Charles River Laboratories International, Inc.
  • 5. Cytiva by Danaher Corporation
  • 6. Eurofins Scientific (Ireland) Limited
  • 7. HiMedia Laboratories, LLC
  • 8. Lonza Group Ltd.
  • 9. Merck KGaA
  • 10. Parker Hannifin Corporation
  • 11. PromoCell GmbH
  • 12. Rad Source Technologies, Inc.
  • 13. Sartorius AG
  • 14. Thermo Fisher Scientific Inc
  • 15. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. VIRAL INACTIVATION MARKET RESEARCH PROCESS
  • FIGURE 2. VIRAL INACTIVATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VIRAL INACTIVATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VIRAL INACTIVATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VIRAL INACTIVATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VIRAL INACTIVATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VIRAL INACTIVATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VIRAL INACTIVATION MARKET DYNAMICS
  • TABLE 7. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY VIRAL INACTIVATION SYSTEMS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PASTEURIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY SOLVENT DETERGENT METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY BLOOD & BLOOD PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CELLULAR & GENE THERAPY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY STEM CELL PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY TISSUES & TISSUE PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY VACCINES & THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. VIRAL INACTIVATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. VIRAL INACTIVATION MARKET, FPNV POSITIONING MATRIX, 2023